See what’s new at Featured CPG • Visit CPG at DeviceTalks Boston, May 27-28, Booth 723 • Join Gavin Braithwaite, CPG’s CEO, Becky Bader, CPG’s Director of Regulatory Services, and Dave Schroeder, Sr. Engineer at Dartmouth Biomedical Engineering Center for Orthopaedics, for a panel discussion on “Smarter Polymer Selection for Safer, More Effective Medical Devices,” Wednesday, May 27, 2:30 p.m. Room 256.
DEA Schedule I through V Controlled Substances License
Cambridge Polymer Group is licensed with the Drug Enforcement Administration (DEA) to maintain and test controlled substances under DEA Schedules 1, 2, 2N, 3, 3N, 4 and 5.
Advance your project with Cambridge Polymer Group’s expert material science solutions.